With 80,000 Participants, the Largest Study of Its Kind Is the First to Evaluate the Benefits of Screening for a Precursor to the Blood Cancer Multiple Myeloma
Doctors do not currently screen asymptomatic individuals for this blood cancer precursor.
- Doctors do not currently screen asymptomatic individuals for this blood cancer precursor.
- The iStopMM study examines the potential benefits versus the potential harms of screening for MGUS.\nThe study\'s leader, Dr. Sigurdur Kristinsson of the University of Iceland, compared screening for precancerous myeloma to screening currently done for precancerous cervical cancer and breast cancer.
- "\nFounded in 1990, the International Myeloma Foundation (IMF) is the first and largest foundation focusing specifically on multiple myeloma.
- In 2012, the IMF launched the Black Swan Research Initiative, a groundbreaking research project aimed at curing myeloma.